Bentham Science Logo

Track Your Manuscript:

Current Medicinal Chemistry

Volume 29, 42 Issues, 2022
ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)
This journal supports open access

Call for Editors

Current Medicinal Chemistry is recruiting Editors in the following areas (and other important areas) of the Journal. If you are interested, then please submit your details for the Editor in Chief’s consideration below.

  1. 3D Printing Pharmaceuticals
  2. Allosteric Modulators
  3. Antibiotic resistance
  4. Antibody-Based Therapeutics
  5. Antioxidants
  6. Antiviral Drug Discovery
  7. Cancer Drug Resistance and Therapeutics
  8. Cancer Immunotherapy
  9. Central Nervous System Drug Discover
  10. Circular RNAs in Cancer
  11. Coronavirus
  12. CRISPR
  13. Drug Discovery Toxicology
  14. Epigenetic polypharmacology
  15. G protein-coupled receptors
  16. High Throughput Screening
  17. Kinase inhibitor
  18. mRNA vaccines
  19. Multidrug resistance modulators
  20. Nano based drug delivery systems
  21. Nanoparticulate nanomedicines
  22. Neurotoxic Proteins
  23. Next generation antibody drugs
  24. Next-Generation Anticancer Metallotherapeutics
  25. NRF2 Modulators in Cancer Therapy
  26. Nutraceuticals
  27. Polymer–drug conjugate therapeutics
  28. Protein Degradation and PROTACs
  29. Proteolysis Targeting
  30. SARS-CoV-2 therapeutics
  31. Sirtuin activators and inhibitors
  32. Target-Based Anticancer Drug Discovery
  33. Targeting Macrophages
  34. Therapeutic Peptides

* If you are willing to become an Editor, in any other section (not listed above), which you feel is relevant to Journals' scope, then please inform us by choosing the “Others” option from the drop down list when you are filling the form below.

  1. Editors are responsible to contribute 1 thematic issue each year in a their area of interest. We expect to receive thematic issue proposals from section editors within 4 months of their appointment, a list of potential authors (with a respectable h-index) within 6 months and the complete thematic issue within 9 months.
  2. Editors are also expected to occasionally solicit/contribute review articles.
  3. Promote the thematic issue amongst the research community to increase its visibility
Selection Criteria:

Selection by the Editor-in-Chief will be based on, but not limited to, the following factors:

  • Interested candidates must at least hold a Doctorate degree
  • A broad and extensive knowledge of the field
  • Previous editorial experience would be desirable

Editor Details

* These fields are mandatory.


Atta-ur-Rahman, FRS
(31099 citations)
Honorary Life Fellow
Kings College
University of Cambridge
View Full Editorial Board

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

COPE Compliant

Cope Logo

Related Journals

Related eBooks

eBooks Catalog